FDA to warn on potential Johnson & Johnson COVID-19 vaccine link to rare disorder, report says

The Food and Drug Administration is reportedly expected to administer a new warning on the Johnson & Johnson COVID-19 vaccine and a possible link to Guillain-Barré, a rare autoimmune nerve disorder.